Agomelatine D6 is a deuterated form of the pharmaceutical compound agomelatine, where six hydrogen atoms are replaced with deuterium. It is used as a stable isotope-labeled compound in pharmaceutical research and manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1079389-42-6
(+/-)-Ondansetron-d5 (methylimidazole-d5)
deuterated active pharmaceutical ingredient
Rifaximin-d6 (Major)
deuterated active pharmaceutical ingredient
Urapidil-d3 (methoxy-d3)
deuterated active pharmaceutical ingredient
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
deuterated active pharmaceutical ingredient
6-fluoro-3-hydroxypyrazine-2-carboxylic acid
Pharmaceutical impurity reference standard
Dimepranol
pharmaceutical raw material
Tilmicosin
veterinary antibacterial antibiotic
Secretin acetate
active pharmaceutical ingredient
2,2,2-trideuterio-N-[2-[7-(trideuteriomethoxy)naphthalen-1-yl]ethyl]acetamide
YJYPHIXNFHFHND-WFGJKAKNSA-N
[2H]C([2H])([2H])C(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC([2H])([2H])[2H]